The Experimental Medicine Initiative to Explore New Therapies (EMINENT) network will be coordinated by University College London (UCL) and will bring together teams of researchers from the Universities of Cambridge, Glasgow, Newcastle, Imperial College London and UCL, with GSK researchers to study the fundamental biological mechanisms responsible for a range of inflammatory diseases. Professor Edwin […]
Dr John Bradley awarded CBE
Dr John Bradley, the director of the NIHR Cambridge BRC, has received a CBE in the Queen’s Birthday honours. Dr Bradley has been instrumental to research carried out across Cambridge University Hospitals, fostering exciting and productive working relationships with the University of Cambridge, other NHS Trusts and industry partners. For more information on his work please refer to […]
Too exhausted to fight – and to do harm
Inside our bodies are billions of immune cells known as T cells that protect us from infection, fighting off attacks from invading bacteria and viruses, and also from cancer. One teaspoon full of blood alone is believed to have around 5 million T cells. But these cells can also do harm, mistaking our own cells […]
Hope for first treatment targeting cause of debilitating heart and lung disease
Genetic evidence dating back to 2000, from research the BHF helped to fund, indicated that the absence or reduced activity of a particular protein, bone morophogenetic protein type II receptor (BMPR-II), leads to pulmonary arterial hypertension. BMPR-II is important to the normal function of the blood vessels of the lungs. Pulmonary arterial hypertension is thought […]
The Big Dating Game
At some point in their career, every doctor will encounter a patient whose condition perplexes them, requiring detailed investigation and discussion with colleagues before diagnosis is possible. After all, not every disease is as common as cancer, which affects around one in three of us, or depression, which affects one in 10. Dr Lucy Raymond […]
Herpes virus hijackers
The common cold sore, caused by herpes simplex virus 1 (HSV-1), is relatively harmless to most people, but for others it can cause life-threatening disease. In intensive care units, for example, the virus commonly leads to severe lung infections. Even in healthy people, in rare cases it can spontaneously cause inflammation of the brain, which […]
Prof. Sharon Peacock has been elected as a member of the European Molecular Biology Organisation (EMBO)
Prof. Sharon Peacock has been elected as a member of the European Molecular Biology Organisation (EMBO). EMBO Members are elected annually in recognition of their contributions to scientific excellence. Selection as a member is thus a tribute to her research and achievements in the scientific community.
Lalita Ramakrishnan elected to the U.S. National Academy of Sciences
Professor Lalita Ramakrishnan announced as one of 84 new members of the U.S. National Academy of Sciences. The National Academy of Sciences has announced the election of 84 new members and 21 foreign associates from 15 countries in recognition of their distinguished and continuing achievements in original research. Lalita Ramakrishnan is a Professor of immunology […]
Prof Margaret Ashcroft to lead a multidisciplinary project partnership and is awarded Honorary Membership of the Royal College of Radiologists
Prof Margaret Ashcroft has been awarded a Cancer Research UK (CR-UK) Bayer Healthcare co-funded drug discovery award to progress her group’s novel hypoxia signalling small molecule inhibitors towards clinical development. Prof Margaret Ashcroft will lead the multidisciplinary project partnership with Bayer, and involves her collaborations with University College London (UCL) School of Pharmacy and Cancer Research […]
Prestigious role for Professor of Clinical Microbiology
Professor Sharon Peacock has been appointed as the first Director of the Bloomsbury Research Institute, a partnership between the London School of Hygiene & Tropical Medicine and UCL dedicated to addressing the global challenge of infectious disease. She will lead the development of a circa £50 million research facility that will bring together more than […]
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 21
- Next Page »